Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study evaluating the combination of cetuximab and gefitinib in colorectal cancer, head and neck canc…
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating rhAngiostatin in combination with paclitaxel and carboplatin for non-small cell lung cancer has completed, report…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A phase 1/2 trial evaluating STA-4783 in combination with paclitaxel and carboplatin in chemotherapy-naïve patients with Stage IIIB/IV non-s…
-
CLINICAL_TRIALS trial_result · 2008-11-11Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer [Phase 1]
Phase 1 study of SU011248 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 randomized trial comparing vinorelbine plus gemcitabine versus docetaxel plus gemcitabine in non-small cell lung cancer has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing Docetaxel versus Vinorelbine as first-line treatment in elderly patients with non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study of SU011248 for metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-15Clinical Trial Update: Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment [Phase 2]
Phase 2 study evaluating continuation of panitumumab in patients who previously benefited and tolerated the drug has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase II trial evaluating cetuximab in combination with carboplatin and docetaxel for patients with …
-
CLINICAL_TRIALS trial_result · 2008-08-20Clinical Trial Update: Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating motexafin gadolinium as second-line treatment for non-small …
-
CLINICAL_TRIALS trial_result · 2008-08-04Clinical Trial Update: Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial comparing gemcitabine/cisplatin versus gemcitabine/epirubicin in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Betamarc for loss of weight and appetite in non-small cell lung cancer; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2008-07-17Clinical Trial Update: Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
This clinical trial update reports the termination of a study evaluating saliva mRNA expression profiling as an early-screening tool for non…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study
This completed clinicopathological study evaluates thoracic tumors in non-small cell lung cancer using PET-CT imaging with 18F-FMT and 18F-F…
-
CLINICAL_TRIALS trial_result · 2008-06-05Clinical Trial Update: Radiofrequency Ablation of Pulmonary Tumors Response Evaluation [Phase 2]
A Phase 2 trial evaluating radiofrequency ablation of pulmonary tumors has completed, focusing on response evaluation for non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 safety study evaluates the safety of combining radiotherapy with erlotinib (Tarceva) for brain metastases in patients with non-…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin and gemcitabine, with or without bevacizumab, for advanced non-small cell lung cancer has be…
-
CLINICAL_TRIALS trial_result · 2008-05-14Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating an HLA-A*2402 restricted peptide vaccine for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-05-05Clinical Trial Update: Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
A Gunma University-sponsored trial assessing angiogenesis using a positron emission tomography tracer in non-small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC [Phase 1]
Phase I trial of bevacizumab plus chemotherapy for malignant pleural effusion in advanced non-small cell lung cancer; the study status is co…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating erlotinib for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This document notes the completion of a Phase 3 trial assessing preoperative twice-daily chemoradiation in addition to chemotherapy before s…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. [Phase 3]
A randomized Phase III trial in stage IIIb and IV non-small cell lung cancer compares sequential single-agent, double-agent, and triple-agen…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating three combinations of docetaxel and irinotecan in patients with recurrent or metastatic non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2008-03-20Clinical Trial Update: Docetaxel in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial of docetaxel in non-small cell lung cancer has been terminated.